Spark Capital

Spark Capital Partners, LLC is a venture capital firm founded in 2005 with offices in San Francisco, Boston, and New York City. The firm specializes in growth capital investments, focusing on early-stage companies across a wide range of sectors, including consumer products, fintech, software, media, and e-commerce. Spark Capital is known for its unique approach to investing, emphasizing support for exceptional products and the creative individuals behind them. The firm embraces risk and aims to help founders achieve success on their own terms, often taking board seats in its portfolio companies. Spark Capital has backed notable companies such as Twitter, Discord, and Warby Parker, demonstrating its commitment to innovative ventures. With investment amounts ranging from $0.5 million to $30 million, the firm targets businesses with revenues up to $1 billion, primarily within the United States but with a global outlook.

Coen Armstrong Ph.D

Investor

Paul Conway

General Partner and CFO

Alex Finkelstein

Co-Founder and General Partner

Clay Fisher

General Partner and Board Observer

Aaditya Jain

Investor, Growth

James Kuklinski

General Partner

Alexa Lyons

Co-CFO and General Partner

Connor Mullaney

Investor

Jeremy Philips

General Partner, Growth

Santo Politi

Co-Founder and General Partner

Yasmin Razavi

General Partner

Will Reed

General Partner

Natalie Sandman

General Partner, Early

Kevin Thau

General Partner

Natalie Vais

General Partner

Nabeel Hyatt

General Partner

Past deals in Infants

Helaina

Series B in 2024
Helaina is a biotechnology company focused on producing milk-equivalent baby formula that serves as an alternative to breast milk. By utilizing fermentation, Helaina generates bioactive proteins that closely mimic the functional proteins found in human milk, creating a new category of functional food products. These products are designed to provide nutritional options and immune benefits similar to those of breast milk, offering infants a viable alternative that incorporates the immune-nourishing properties of natural breast milk. Helaina's innovative approach aims to enhance infant nutrition and support healthy development.

Helaina

Series A in 2021
Helaina is a biotechnology company focused on producing milk-equivalent baby formula that serves as an alternative to breast milk. By utilizing fermentation, Helaina generates bioactive proteins that closely mimic the functional proteins found in human milk, creating a new category of functional food products. These products are designed to provide nutritional options and immune benefits similar to those of breast milk, offering infants a viable alternative that incorporates the immune-nourishing properties of natural breast milk. Helaina's innovative approach aims to enhance infant nutrition and support healthy development.

Helaina

Seed Round in 2020
Helaina is a biotechnology company focused on producing milk-equivalent baby formula that serves as an alternative to breast milk. By utilizing fermentation, Helaina generates bioactive proteins that closely mimic the functional proteins found in human milk, creating a new category of functional food products. These products are designed to provide nutritional options and immune benefits similar to those of breast milk, offering infants a viable alternative that incorporates the immune-nourishing properties of natural breast milk. Helaina's innovative approach aims to enhance infant nutrition and support healthy development.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.